OAR@UM Collection:https://www.um.edu.mt/library/oar/handle/123456789/298812026-04-14T07:10:26Z2026-04-14T07:10:26ZAssessment of glycaemic control in diabetic patients undergoing percutaneous coronary interventionWittezaele, JennyWirth, FrancescaXuereb, Robert G.Sterbaut, StephaneAzzopardi, Lilian M.https://www.um.edu.mt/library/oar/handle/123456789/1327622025-03-05T07:27:02Z2015-01-01T00:00:00ZTitle: Assessment of glycaemic control in diabetic patients undergoing percutaneous coronary intervention
Authors: Wittezaele, Jenny; Wirth, Francesca; Xuereb, Robert G.; Sterbaut, Stephane; Azzopardi, Lilian M.
Abstract: Introduction: In diabetic patients, hyperglycaemia triggers an inflammatory response involved in the process of atherosclerosis and platelet hyperactivity may lead to increased platelet aggregation and vascular occlusion. The aim was to assess glycaemic control in patients with type 2 diabetes mellitus (DM) who were undergoing percutaneous coronary intervention (PCI).2015-01-01T00:00:00ZCardiac rehabilitation in patients after percutaneous coronary interventionTadiotto, MicheleWirth, FrancescaDesira, JosetteXuereb, CliffordXuereb, Robert G.Cignarella, AndreaAzzopardi, Lilian M.https://www.um.edu.mt/library/oar/handle/123456789/1327612025-03-05T07:25:26Z2015-01-01T00:00:00ZTitle: Cardiac rehabilitation in patients after percutaneous coronary intervention
Authors: Tadiotto, Michele; Wirth, Francesca; Desira, Josette; Xuereb, Clifford; Xuereb, Robert G.; Cignarella, Andrea; Azzopardi, Lilian M.
Abstract: Introduction: A multidisciplinary cardiac rehabilitation (CR) program supports patients to implement long -term lifestyle changes to improve prognosis after percutaneous coronary intervention (PCI). The aims were to assess patients' response to the outpatient CR program offered at Mater Dei Hospital, follow-up patients to assess their progress with lifestyle changes and analyse pharmacist contribution in CR.2015-01-01T00:00:00ZCYP2C19 loss-of-function *2 allele and coronary in-stent restenosisWirth, FrancescaZahra, GraziellaXuereb, Robert G.Barbara, ChristopherFenech, AlbertAzzopardi, Lilian M.https://www.um.edu.mt/library/oar/handle/123456789/1327602025-03-04T08:24:09Z2015-01-01T00:00:00ZTitle: CYP2C19 loss-of-function *2 allele and coronary in-stent restenosis
Authors: Wirth, Francesca; Zahra, Graziella; Xuereb, Robert G.; Barbara, Christopher; Fenech, Albert; Azzopardi, Lilian M.
Abstract: Introduction: The CYP2C19 *2 allele is associated with reduced response to clopidogrel which may increase the risk of stent thrombosis after percutaneous coronary intervention (PCI). This allele has recently been linked with peripheral and vertebral artery in-stent restenosis (ISR). The aim was to determine whether there is an association between *2 allele carrier status and coronary ISR.2015-01-01T00:00:00ZPharmacist-led personalisation of antiplatelet therapyWirth, FrancescaZahra, GraziellaXuereb, Robert G.Barbara, ChristopherFenech, AlbertAzzopardi, Lilian M.https://www.um.edu.mt/library/oar/handle/123456789/1327572025-03-04T07:34:54Z2015-01-01T00:00:00ZTitle: Pharmacist-led personalisation of antiplatelet therapy
Authors: Wirth, Francesca; Zahra, Graziella; Xuereb, Robert G.; Barbara, Christopher; Fenech, Albert; Azzopardi, Lilian M.
Abstract: Introduction: Pharmacists should strive to take a leading role in the clinical implementation of pharmacogenetics to personalise antiplatelet therapy. The aim was to compare a novel point-of-care (POC) and two robust laboratory-based assays to identify presence of the CYP2C19 *2 allele in patients prescribed clopidogrel therapy.2015-01-01T00:00:00Z